-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Anchor targets, give it your all in the final sprint! Keyuan Pharmaceutical holds its marketing work conference, focusing on tackling and achieving targets from multiple angles!
Publish Time:
2025-06-02
Recently, Keyuan Pharmaceutical held a special marketing work conference. Chairman and President Gao Chunpo, along with the management team and core members of the sales team, attended the meeting in full force. The discussion centered on accelerating target achievement, strengthening cost control to boost efficiency, and strategically positioning new products for breakthroughs. Focusing on these three key areas, the meeting laid out priorities for the next phase, emphasizing a determined, multi-pronged approach to fully commit to meeting and exceeding the company’s targets.
Recently, Keyuan Pharmaceutical held a special marketing work conference. Chairman and President Gao Chunpo, along with the management team and core members of the sales team, attended the meeting in full force. The discussion centered on accelerating target achievement, strengthening efforts to reduce costs and boost efficiency, and strategically positioning new products for breakthroughs. Focusing on these three key areas, the meeting laid out priorities for the next phase, emphasizing a determined, multi-pronged approach to fully drive progress toward meeting critical targets.
At the meeting, personnel from each sales region delivered detailed reports on their progress toward the January-May targets, thoroughly reviewing both the standout achievements and areas needing improvement in their work. Chairman Gao Chunpo urged the marketing team to stay focused on their objectives, breaking down the remaining targets into specific, actionable steps and assigning clear accountability to individual team members. He also emphasized strengthening collaboration with departments such as production, R&D, and finance, fostering a cohesive "united front—aligned vertically and horizontally"—to create a powerful synergy that will drive momentum forward. This approach will provide robust support for successfully achieving the company's goals for the second half of the year and beyond.
The meeting emphasized that each sales unit must strengthen its goal-oriented approach, leveraging initiatives such as introducing new products and innovating trade strategies to close the performance gap, thereby making every effort to achieve targeted results. Regarding market expansion, the meeting urged the optimization of sales policies to provide more tailored support to frontline teams. At the same time, leaders were asked to proactively address special orders by coordinating pricing discussions early on with senior management and finance departments, ensuring maximum overall business efficiency.
The meeting noted that improving quality, reducing costs, and enhancing efficiency remain the fundamental tasks at this stage. Each sales unit needs to conduct a thorough cost review of its core products—starting from optimizing production processes and boosting raw-material utilization at the manufacturing end, all the way to aligning sales policies with cost assessments at the distribution end—thereby establishing a collaborative mechanism that integrates "cost reduction in production, efficiency gains in sales, and expense control through management."
The meeting identified the introduction of new products as the key to breaking the current stalemate. By implementing a dedicated project supervision mechanism, the team will accelerate the commercialization process, ensuring short-term growth in sales. At the same time, the R&D system is tasked with aligning its project selection logic more closely with market demands, strengthening early-stage collaboration with production and sales teams to prevent disconnects between technology and market needs. For areas where the company holds competitive advantages, simultaneous efforts will be made to upgrade production capacity and optimize the customer portfolio, reserving sufficient resources for the successful launch of new products.
The convening of this meeting serves as a "powerful boost" to drive the achievement of future targets. The company will comprehensively advance its strategy of stabilizing the core business through "cost reduction," while simultaneously expanding growth opportunities with "new products." We’ll focus on integrating resources and enhancing execution efficiency, boldly tackling challenges head-on and giving it our all to sprint toward the realization of our business objectives!
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline